228 related articles for article (PubMed ID: 10646871)
21. Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells.
Miyaki M; Tanaka K; Kikuchi-Yanoshita R; Muraoka M; Konishi M; Takeichi M
Oncogene; 1995 Dec; 11(12):2547-52. PubMed ID: 8545111
[TBL] [Abstract][Full Text] [Related]
22. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
[TBL] [Abstract][Full Text] [Related]
23. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
24. Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines.
Bindels EM; Vermey M; De Both NJ; van der Kwast TH
Virchows Arch; 2001 Oct; 439(4):552-9. PubMed ID: 11710643
[TBL] [Abstract][Full Text] [Related]
25. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
Sun W; Herrera GA
Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
[TBL] [Abstract][Full Text] [Related]
26. Differential accumulation of hypericin in spheroids composed of T-24 transitional cell carcinoma cells expressing different levels of E-cadherin.
Huygens A; Crnolatac I; Develter J; Van Cleynenbreugel B; Van der Kwast T; de Witte PA
J Urol; 2008 May; 179(5):2014-9. PubMed ID: 18355860
[TBL] [Abstract][Full Text] [Related]
27. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors.
Bringuier PP; Umbas R; Schaafsma HE; Karthaus HF; Debruyne FM; Schalken JA
Cancer Res; 1993 Jul; 53(14):3241-5. PubMed ID: 8324734
[TBL] [Abstract][Full Text] [Related]
28. Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma.
Hong RL; Pu YS; Hsieh TS; Chu JS; Lee WJ
J Urol; 1995 Jun; 153(6):2025-8. PubMed ID: 7538603
[TBL] [Abstract][Full Text] [Related]
29. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
[TBL] [Abstract][Full Text] [Related]
30. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
Dyrskjøt L; Kruhøffer M; Thykjaer T; Marcussen N; Jensen JL; Møller K; Ørntoft TF
Cancer Res; 2004 Jun; 64(11):4040-8. PubMed ID: 15173019
[TBL] [Abstract][Full Text] [Related]
31. Reduction of integrin beta4 and enhanced migration on laminin in association with intraepithelial spreading of urinary bladder carcinomas.
Harabayashi T; Kanai Y; Yamada T; Sakamoto M; Ochiai A; Kakizoe T; Koyanagi T; Hirohashi S
J Urol; 1999 Apr; 161(4):1364-71. PubMed ID: 10081909
[TBL] [Abstract][Full Text] [Related]
32. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection.
Luo J; Lubaroff DM; Hendrix MJ
Cancer Res; 1999 Aug; 59(15):3552-6. PubMed ID: 10446959
[TBL] [Abstract][Full Text] [Related]
33. p130Cas, E-cadherin and β-catenin in human transitional cell carcinoma of the bladder: expression and clinicopathological significance.
Hu X; Ruan Y; Cheng F; Yu W; Zhang X; Larré S
Int J Urol; 2011 Sep; 18(9):630-7. PubMed ID: 21672035
[TBL] [Abstract][Full Text] [Related]
34. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
[TBL] [Abstract][Full Text] [Related]
35. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
[TBL] [Abstract][Full Text] [Related]
36. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
37. P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells.
Mandeville JA; Silva Neto B; Vanni AJ; Smith GL; Rieger-Christ KM; Zeheb R; Loda M; Libertino JA; Summerhayes IC
BJU Int; 2008 Dec; 102(11):1707-14. PubMed ID: 18990147
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP
J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817
[TBL] [Abstract][Full Text] [Related]
39. A causal role for E-cadherin in the transition from adenoma to carcinoma.
Perl AK; Wilgenbus P; Dahl U; Semb H; Christofori G
Nature; 1998 Mar; 392(6672):190-3. PubMed ID: 9515965
[TBL] [Abstract][Full Text] [Related]
40. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]